Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H7ClN2 |
Molecular Weight | 142.586 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=C(N)C=C(Cl)C=C1
InChI
InChIKey=BXIXXXYDDJVHDL-UHFFFAOYSA-N
InChI=1S/C6H7ClN2/c7-4-1-2-5(8)6(9)3-4/h1-3H,8-9H2
Molecular Formula | C6H7ClN2 |
Molecular Weight | 142.586 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
4-Chloro-o-phenylenediamine is a chlorinated aromatic amine that
exists as a brown crystalline solid or powder at room temperature. 4-Chloro-o-phenylenediamine can be used as an oxidation base for
dye preparation, as a chemical intermediate to produce 5-chlorobenzotriazole,
as a curing agent for epoxy resins, as a reagent in gas
chromatography, and to synthesize experimental pharmaceuticals.
It has been used as a chemical intermediate in dye production and
was patented as a hair-dye component. Oral exposure to 4-chloro-o-phenylenediamine caused tumors in
two rodent species and at several different tissue sites. Dietary administration
of technical-grade 4-chloro-o-phenylenediamine caused
benign or malignant liver tumors (hepatocellular adenoma or carcinoma)
in mice of both sexes and benign or malignant tumors of the
urinary bladder and forestomach (papilloma or carcinoma) in rats
of both sexes (NCI 1978).
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10592323
In an initial 2-week study 4-C-o-PDA (4-Chloro-o-phenylenediamine) was administered daily per os to groups of male and female C57BL/6 Big Blue mice at doses of 0 and 200 mg/kg for 2 weeks (on working days) followed by a treatment free expression time of 10 days. Only a weak increase in the mutant frequencies in females was observed. In a 26-week study, where 4-C-o-PDA was given to groups of male and female Big Blue mice in feed at dietary concentrations of 0, 5,000 and 10,000 ppm, 4-C-o-PDA was found to induce a pronounced dose-dependent increase in mutant frequencies in either sex.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18058049
4-Chloro-o-phenylenediamine within the range of doses from 100 uM to 500 uM showed the genotoxicity in a dose-dependent manner after the incubation of lymphocytes for 2 h.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:56:55 GMT 2023
by
admin
on
Sat Dec 16 08:56:55 GMT 2023
|
Record UNII |
8E72QRZ33H
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
8E72QRZ33H
Created by
admin on Sat Dec 16 08:56:55 GMT 2023 , Edited by admin on Sat Dec 16 08:56:55 GMT 2023
|
PRIMARY | |||
|
202-456-8
Created by
admin on Sat Dec 16 08:56:55 GMT 2023 , Edited by admin on Sat Dec 16 08:56:55 GMT 2023
|
PRIMARY | |||
|
DTXSID5020283
Created by
admin on Sat Dec 16 08:56:55 GMT 2023 , Edited by admin on Sat Dec 16 08:56:55 GMT 2023
|
PRIMARY | |||
|
95-83-0
Created by
admin on Sat Dec 16 08:56:55 GMT 2023 , Edited by admin on Sat Dec 16 08:56:55 GMT 2023
|
PRIMARY | |||
|
5087
Created by
admin on Sat Dec 16 08:56:55 GMT 2023 , Edited by admin on Sat Dec 16 08:56:55 GMT 2023
|
PRIMARY | |||
|
7263
Created by
admin on Sat Dec 16 08:56:55 GMT 2023 , Edited by admin on Sat Dec 16 08:56:55 GMT 2023
|
PRIMARY | |||
|
6157
Created by
admin on Sat Dec 16 08:56:55 GMT 2023 , Edited by admin on Sat Dec 16 08:56:55 GMT 2023
|
PRIMARY |